In hematological malignancies, FHIT methylation has been seen in some cases of myelodysplastic syndrome (MDS), acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL), and chronic myelogenous leukemia (CML) [27–29]. The gene discussed is FHIT; the disease is myelodysplastic syndrome.